Evidence map›Paper›PMID 28900161›Full record

ArticleScientific reports2017

Acetyl-4'-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency.

Ivano Di Meo, Cristina Colombelli, Balaji Srinivasan, Marianne de Villiers, Jeffrey Hamada, Suh Y Jeong, Rachel Fox, Randall L Woltjer, Pieter G Tepper, Liza L Lahaye and 12 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. PKAN pathogenesis and treatment.Molecular genetics and metabolism · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 5 countries.

Ivano Di MeoDivision of Molecular Neurogenetics, IRCCS Foundation Neurological Institute "C.Besta" Via Temolo 4, 20126, Milano, Italy.ORCID 0000-0002-4616-5623
Cristina ColombelliDivision of Molecular Neurogenetics, IRCCS Foundation Neurological Institute "C.Besta" Via Temolo 4, 20126, Milano, Italy.
Balaji SrinivasanDepartment of Cell Biology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Marianne de VilliersDepartment of Biochemistry, Stellenbosch University, Stellenbosch, 7600, South Africa.
Jeffrey HamadaDepartments of Molecular & Medical Genetics and Pathology, Oregon Health & Science University, Portland, OR, 97239, USA.
Suh Y JeongDepartments of Molecular & Medical Genetics and Pathology, Oregon Health & Science University, Portland, OR, 97239, USA.
Rachel FoxDepartments of Molecular & Medical Genetics and Pathology, Oregon Health & Science University, Portland, OR, 97239, USA.
Randall L WoltjerDepartments of Molecular & Medical Genetics and Pathology, Oregon Health & Science University, Portland, OR, 97239, USA.
Pieter G TepperDepartment of Chemical and Pharmaceutical Biology, University of Groningen, Ant. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Liza L LahayeDepartment of Cell Biology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Emanuela RizzettoClinical Pathology and Medical Genetics Unit, Foundation IRCCS-Neurological Institute "Carlo Besta", Milano, Italy.
Clara H HarrsDepartment of Cell Biology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Theo de BoerAnalytical Biochemical Laboratory (ABL), WA Scholtenstraat 7, 9403 AJ, Assen, The Netherlands.
Marianne van der ZwaagDepartment of Cell Biology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Branko JenkoAcies Bio d.o.o., Tehnološki park 21, 1000, Ljubljana, Slovenia.
Alen ČusakAcies Bio d.o.o., Tehnološki park 21, 1000, Ljubljana, Slovenia.
Jerca PahorAcies Bio d.o.o., Tehnološki park 21, 1000, Ljubljana, Slovenia.
Gregor KosecAcies Bio d.o.o., Tehnološki park 21, 1000, Ljubljana, Slovenia.
Nicola A GrzeschikDepartment of Cell Biology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Susan J HayflickDepartments of Molecular & Medical Genetics and Pathology, Oregon Health & Science University, Portland, OR, 97239, USA.
Valeria TirantiDivision of Molecular Neurogenetics, IRCCS Foundation Neurological Institute "C.Besta" Via Temolo 4, 20126, Milano, Italy.ORCID 0000-0002-3584-7338
Ody C M SibonDepartment of Cell Biology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV, Groningen, The Netherlands. o.c.m.sibon@umcg.nl.
University Medical Center Groningen · NLOregon Health & Science University · USAcies Bio (Slovenia) · SIFondazione IRCCS Istituto Neurologico Carlo Besta · ITJožef Stefan Institute · SIStellenbosch University · ZAUniversity of Groningen · NL

Funding

PKAN pathogenesis and treatmentR01NS109083 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI HAYFLICK, SUSAN J · 2018 to 2020
$1.0M
Coenzyme A replenishment as a therapeutic strategy for inborn errors of metabolismR21HD088833 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI HAYFLICK, SUSAN J · 2017 to 2018
$424k
NICHD NIH HHS R21 HD088833NINDS NIH HHS R01 NS109083
6 · The paper itself

Abstract

Coenzyme A is an essential metabolite known for its central role in over one hundred cellular metabolic reactions. In cells, Coenzyme A is synthesized de novo in five enzymatic steps with vitamin B5 as the starting metabolite, phosphorylated by pantothenate kinase. Mutations in the pantothenate kinase 2 gene cause a severe form of neurodegeneration for which no treatment is available. One therapeutic strategy is to generate Coenzyme A precursors downstream of the defective step in the pathway. Here we describe the synthesis, characteristics and in vivo rescue potential of the acetyl-Coenzyme A precursor S-acetyl-4'-phosphopantetheine as a possible treatment for neurodegeneration associated with pantothenate kinase deficiency.

Indexed as

AnimalsCell LineDisease Models, AnimalDrosophilaHeredodegenerative Disorders, Nervous SystemHumansMicePantetheinePhosphotransferases (Alcohol Group Acceptor)SerumTreatment Outcome4'-phosphopantetheinePantetheinepantothenate kinasePhosphotransferases (Alcohol Group Acceptor)

Identifiers

PMID28900161
PMCPMC5595861
OpenAlexW2751763563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.